Related Experiment Videos

Miss the ear, and you may miss the diagnosis

Ranjit Nair¹, Yehia Y Mishriki²

¹Lehigh Valley Health Network, Allentown, PA ranjit_r.nair@lvhn.org.

Cleveland Clinic Journal of Medicine

|November 5, 2014

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Safety of concurrent radiation therapy with the antibody-drug conjugate polatuzumab vedotin in relapsed or refractory aggressive B-cell lymphomas.

Practical radiation oncology·2026

Pre-infusion plasma proteomics identifies an endothelial-immune priming signature predictive of severe cytokine release syndrome and neurotoxicity following CAR T-cell therapy in relapsed/refractory lymphoma.

medRxiv : the preprint server for health sciences·2026

Clinical trial access after CAR T-cell therapy failure in relapsed/refractory large B-cell lymphoma.

British journal of haematology·2026

Frontline acalabrutinib, lenalidomide and rituximab for advanced stage follicular lymphoma with high tumor burden: phase II trial.

Nature communications·2025

Novel devimistat results in complete remissions in heavily pretreated Burkitt lymphoma in a phase 2 trial.

Blood advances·2025

Tricuspid regurgitation and chronic kidney disease in patients with cardiogenic shock: Review of the literature and real-world experience from a single center.

International journal of cardiology. Heart & vasculature·2025

See all related articles